Picture of Nykode Therapeutics ASA logo

NYKD — Nykode Therapeutics ASA News Story

0.000.00%
no flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapMomentum Trap

Brief: Nykode Receives U.S. Patent For Neoantigen Selection Method

Nov 4 (Reuters) - Nykode Therapeutics ASA NYKD.OL:

NYKODE THERAPEUTICS STRENGTHENS INTELLECTUAL PROPERTY PORTFOLIO WITH NEW U.S. PATENT FOR THE NEOANTIGEN SELECTION METHOD FOR VB10.NEO, NYKODE'S INDIVIDUALIZED NEOANTIGEN THERAPY

Source text: ID:nObixbBC7a

Further company coverage: NYKD.OL

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))

Recent news on Nykode Therapeutics ASA

See all news